Cite
HARVARD Citation
Biran, N. et al. (2021). Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high‐risk multiple myeloma. American journal of hematology. 96 (11), pp. E430-E433. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Biran, N. et al. (2021). Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high‐risk multiple myeloma. American journal of hematology. 96 (11), pp. E430-E433. [Online].